购物车
0
有库存
HIT212712076
 sdf 文件
结构编辑
类似物检索
HIT212712076
  • HIT ID:HIT212712076
  • Cas No:132640-22-3
  • 常用名:Andolast
  • 别名:CR-2039, CR2039, CR 2039
  • IUPAC:4-(1H-1,2,3,4-tetrazol-5-yl)-N-[4-(1H-1,2,3,4-tetrazol-5-yl)phenyl]benzamide
    IUPAC:4-(1H-1,2,3,4-tetrazol-5-yl)-N-[4-(1H-1,2,3,4-tetrazol-5-yl)phenyl]benzamide
  • InChI key:VXEBMQZDPONDFB-UHFFFAOYSA-N
  • 分子式:C15H11N9O
  • 分子量:333.315
  • 氢键供体数 (HBD):3
  • 氢键受体数 (HBA):7
  • LogP:1.6262507
  • SMILES:O=C(Nc1ccc(cc1)-c1nnn[nH]1)c1ccc(cc1)-c1nnn[nH]1
    SMILES:O=C(Nc1ccc(cc1)-c1nnn[nH]1)c1ccc(cc1)-c1nnn[nH]1
  • Andolast, also known as CR-2039, an anti-allergic agent for the treatment of bronchial asthma, chronic obstructive pulmonary disease (COPD). Andolast acts at different cellular levels to inhibit immunoglobulin E synthesis. Andolast proved to be significantly more effective than placebo in improving airflow, and in controlling asthma symptoms both during day and night.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    6-8周
    纯度
    -
    ¥ 10,600.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~